Vertex Opens New Front In Patient Assistance Conflict Between Pharma, HHS Inspector General

 
• By Cathy Kelly

Vertex’s fertility preservation assistance program would provide up to $70,000 in financial support for in vitro fertilization and other services to patients prescribed Casgevy.

Vertex is challenging the HHS Government Watchdog.

More from Cell & Gene Therapies

More from Advanced Technologies